BioSpace News Archive

Pharm Country

Bayer Presents Five-Year Outcomes Data from the PROTECT VIII Extension Study at the 60th American Society of Hematology Annual Meeting

Study finds long-term safety and efficacy in subset of 33 hemophilia A patients who received treatment with Jivi® (antihemophilic factor [recombinant] PEGylated-aucl) for five years was consistent with previous data analysis

December 4, 2018
·
6 min read
Biotech Beach

Grow Pod Solutions has Medical Grade Cultivation for Lettuce and Vegetables Without Risk of E.coli

The company’s proprietary sealed indoor growing pods use advanced technology to grow food in a pure, clean environment

December 4, 2018
·
2 min read
Genetown

Yumanity Therapeutics Announces Publication of Paper in Cell Reports Detailing a Potential New Therapeutic Target for the Treatment of Parkinson’s Disease

Results suggest inhibiting fatty acid desaturation by blocking the enzyme stearoyl-CoA desaturase (SCD) is a potential therapeutic approach to treating neurodegenerative diseases

December 4, 2018
·
5 min read
Mylan Expands its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to All Lots Within Expiry Due to the Detection of Trace Amounts of NDEA

Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within expiry.

December 4, 2018
·
11 min read
BioMidwest

Two Northwestern Medicine Hospitals Earn 2018 Leapfrog Top Hospital Award

Two Northwestern Medicine hospitals are recognized by The Leapfrog Group with its 2018 Top Hospital Award.

December 4, 2018
·
2 min read
Business

Mperia Therapeutics Adds Experts in Drug Delivery, Dry AMD & Atherosclerosis to CAB

CEO & President Paul Chipperton is pleased to announce today the appointment of Dr Daniel Saban, PhD; Dr Szilard Voros PhD, MD; and Dr Jean-Christophe Leroux, PhD; to the company’s Clinical Advisory Board (CAB).

December 4, 2018
·
3 min read
Deals

SQI Diagnostics to Extend Warrant Expiry to December 15, 2020

SQI Diagnostics Inc. today announced that it intends to extend the expiry of 7,630,945 outstanding common share purchase warrants (“the Warrants”) of the Company, which were issued in connection with the Company’s December 2015 private placement financing.

December 4, 2018
·
3 min read
Drug Development

IMBRUVICA® (ibrutinib) Combination Regimen Significantly Improved Survival Versus the Chemoimmunotherapy FCR (Fludarabine, Cyclophosphamide and Rituximab) in Previously Untreated and Younger Chronic Lymphocytic Leukemia (CLL) Patients

Results from this interim analysis showed ibrutinib plus rituximab prolonged progression-free survival (PFS) compared to a standard chemoimmunotherapy regimen of fludarabine, cyclophosphamide and rituximab (FCR) at nearly 3 years of follow-up (abstract #LBA-4)

December 4, 2018
·
14 min read
Job Trends

Octapharma USA Sponsored Bombardier Blood Presented by Denver Mountain Climber During Special Hometown Screening

Documentary Features Chris Bombardier’s Quest to Climb the Seven Summits

December 4, 2018
·
3 min read